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Severe malaria anemia is one of the most common causes of morbidity and mortality
arising from infection with Plasmodium falciparum. The pathogenesis of malarial anemia
is complex, involving both parasite and host factors. As mouse models of malaria also
develop anemia, they can provide a useful resource to study the impact of Plasmodium
infections and the resulting host innate immune response on erythropoiesis. In this
study, we have characterized the bone marrow and splenic responses of the erythroid
as well as other hematopoietic lineages after an acute infection of Balb/c mice with
Plasmodium berghei. Such characterization of the hematopoietic changes is critical to
underpin future studies, using knockout mice and transgenic parasites, to tease out
the interplay between host genes and parasite modulators implicated in susceptibility
to malaria anemia. P. berghei infection led to a clear perturbation of steady-state
erythropoiesis, with the most profound defects in polychromatic and orthochromatic
erythroblasts as well as erythroid colony- and burst-forming units (CFU-E and BFU-E),
resulting in an inability to compensate for anemia. The perturbation in erythropoiesis
was not attributable to parasites infecting erythroblasts and affecting differentiation,
nor to insufficient erythropoietin (EPO) production or impaired activation of the Signal
transducer and activator of transcription 5 (STAT5) downstream of the EPO receptor,
indicating EPO-signaling remained functional in anemia. Instead, the results point to
acute anemia in P. berghei-infected mice arising from increased myeloid cell production
in order to clear the infection, and the concomitant release of pro-inflammatory cytokines
and chemokines from myeloid cells that inhibit erythroid development, in a manner that
resembles the pathophysiology of anemia of chronic disease.
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INTRODUCTION
Malaria is a global health problem caused by infection with parasites belonging to the genus
Plasmodium. In 2016, there were∼216 million episodes of malaria resulting in an estimated 445,000
deaths (WHO, 2017). Plasmodium falciparum is responsible for the majority of the disease burden
and the most common pathology that arises as a result of infection is moderate to severe malaria
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anemia. Infection with non-falciparum species can also give
rise to anemia. Severe malaria anemia (SMA) is defined as a
hemoglobin concentration ≤5 g/dl or hematocrit <15% for
children under the age of 12 (or 7 g/dl or hematocrit <20%
for adults), in conjunction with a high parasitemia (>10,000
parasites/µl blood) and a normocytic blood film whereas
patients with mild anemia have a hemoglobin concentration
≤11 g/dl (WHO Tropical Medicine and International Health,
2014). The anemia of P. falciparum malaria is typified by low
numbers of red blood cells (RBCs), with a pronounced absence
of reticulocytes (Roberts et al., 2005). Thrombocytopenia,
splenomegaly, hepatomegaly and jaundice can also be observed
in patients with SMA and increased hemolysis and bone marrow
suppression is additionally evident (Helleberg et al., 2005).
The pathogenesis of malarial anemia is multi-factorial and
both parasite and host-mediated factors play a role [reviewed
in Lamikanra et al. (2007)]. Anemia develops rapidly in
patients with severe malaria arising from P. falciparum infection.
Parasitized RBCs (pRBCs) are destroyed as a result of maturation
of parasites into schizonts and subsequent rupture from RBCs.
The pRBCs are also destroyed by the mononuclear phagocyte
system in the spleen, which recognize the presence of foreign
parasite antigens on the surface of pRBCs (Patel et al., 2004).
Destruction of pRBCs may involve antibody-dependent cell-
mediated cytotoxicity (ADCC) (Arora et al., 2016), complement-
dependent killing (Boyle et al., 2015) or opsonin-independent
killing mechanisms (Su et al., 2002). However, it is the hemolysis
of uninfected RBCs that is the more significant contributor to
the rapid development of anemia and low hematocrit observed
in patients with hyperparasitemia (Looareesuwan et al., 1987;
Dondorp et al., 1997) since for every pRBC removed or
destroyed by the mononuclear phagocyte system, at least ten
uninfected RBCs (uRBCs) are removed from the circulation
(Evans et al., 2006).
Alteration to the maturation and/or differentiation of
RBCs leading to fewer RBCs leaving the bone marrow is
also a contributing factor to anemia (Wickramasinghe and
Abdalla, 2000). Moreover, the production of abnormal RBCs
(dyserythropoiesis) has also been observed in marrow aspirates
taken from patients infected with P. falciparum and Plasmodium
vivax (Abdalla and Wickramasinghe, 1988; Wickramasinghe
et al., 1989). However, the mechanisms that give rise to
insufficient erythropoiesis and dyserthropoiesis are still poorly
defined. In healthy individuals, erythropoiesis is regulated by
erythropoietin (EPO) that is secreted by the kidney in response
to hypoxia. EPO binds to the EPO-receptor on hematopoietic
cells (Youssoufian et al., 1993), leading to the downstream
activation of the Janus kinase 2 (JAK2) - Signal transducer
and activator of transcription 5 (STAT5) pathway (Witthuhn
et al., 1993; Socolovsky et al., 2001) and the differentiation and
proliferation of cells within the erythrocytic lineage to generate
mature RBCs. Erythropoiesis is also regulated by stem cell factor
(SCF) binding to the c-Kit receptor, which in concert with
EPO-receptor signaling induces progenitor survival (Dolznig
et al., 2001). Clinical evaluation of patients with SMA has
revealed this pathology is characterized by significantly lower
numbers of erythroid colony-forming cells [specifically the burst
forming units (BFU-E)], premature death of erythroblasts and
low reticulocytosis (Wickramasinghe et al., 1982; Maggio-Price
et al., 1985; Abdalla and Wickramasinghe, 1988; Jootar et al.,
1993). It remains unclear whether deficiency of EPO is a major
contributor to inadequate erythropoiesis in malaria. In several
human studies, EPO production was defective or levels were
not as high as would be expected for the degree of anemia
observed (Burgmann et al., 1996; El Hassan et al., 1997; Vedovato
et al., 1999; Leowattana et al., 2008), however, other studies
reported elevated levels of EPO in the serum of African children
with severe P. falciparum-related anemia (Burchard et al., 1995;
Verhoef et al., 2002).
Various parasite mediators such as hemozoin (a by-product
of hemoglobin digestion by Plasmodium) (Pagola et al., 2000)
and glycosylphosphatidylinositols (GPIs) attached to parasite
antigens have been shown to affect erythropoiesis during a
Plasmodium infection. Hemozoin promotes premature apoptosis
of erythroid precursors (Lamikanra et al., 2009) and causes
dysregulation in the innate immune response (Perkins et al.,
2011), influencing the production of pro-inflammatory cytokines
and chemokines. Indeed, the balance between pro- and anti-
inflammatory cytokines is likely to be a critical determinant of
anemia. Several of these cytokines, such as TNF-α and IFN-γ play
a protective role in malaria by arresting parasite replication and
enhancing parasite killing (Clark et al., 1990), but also contribute
to anemia by inhibiting erythropoiesis (Miller et al., 1989;
Dufour et al., 2003).
To date the effect of Plasmodium infection on erythropoiesis
has been studied in a variety of different contexts, including in
patients, using in vitro erythroblast infections, and in various
mouse models of Plasmodium infection and anemia [for a
review, see Lamikanra et al. (2009)]. However, there are limited
studies examining the interplay between the erythrocytic and
the hematopoietic compartments more broadly in response
to a Plasmodium infection, which together influence whether
optimal pro-inflammatory and erythropoietic responses can be
mounted to fight infection and prevent anemia. In this study, we
examined the erythropoietic and wider hematopoietic responses
that occur in the bone marrow and spleen of Balb/c mice after
an acute infection with Plasmodium berghei, a rodent malaria
strain which is most widely used for gene knockout studies. Such
characterization is critical to underpin future studies to tease
out and validate the interplay between parasite modulators and
host genes that determine susceptibility to malaria anemia that
have, for example, been identified through human genome wide
association studies.
MATERIALS AND METHODS
Mice and Ethics Approval
In this study, female Balb/c mice of 6–8 weeks of age were
used as donor and recipient mice for P. berghei infection. Mice
were housed under controlled conditions at 21◦C temperature
with a 12:12 h light:dark cycle. All experiments involving the
use of animals were performed in strict accordance with the
recommendations of the National Health and Medical Research
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Council Australian ‘Code of practice for the care and use of
animals for scientific purposes.’ The protocols were approved
by the Deakin University Animal Welfare Committee (approval
numbers G37/2013 and G08/2017).
Infection of Mice With P. berghei
Mice were infected with wild-type P. berghei ANKA and
P. berghei EXP2-2A-FRT, the latter expressing an exported GFP
reporter (KAHRPL-GFP), in which the sequence of KAHRP
(P. falciparum knob-associated histidine-rich protein) that
directs export into the host RBC is fused in frame to GFP, under
the transcriptional control of the HSP70 promoter (Kalanon
et al., 2016). For infection studies, 106 parasitized RBCs (pRBCs)
were injected into the intraperitoneal cavity (n = 6 mice/group).
Infections were initiated on either day 0 (d0) or 3 days later
(d3) and parasitemia was determined daily by counting Giemsa-
stained blood smears, with a minimum of 1,000 RBC counted.
On the 8th day, all mice (thus infected for either 8 days or
5 days, respectively) as well as control uninfected mice were
humanely killed.
Mouse Blood Analysis
For measuring hematological parameters such as hemoglobin
and hematocrit, 20 µl mouse blood was collected using
minivettes (SarstedtTM) and analyzed using a hematology
analyzer according to the manufacturer’s instructions (SCIL).
Harvesting of Mouse Bone Marrow and
Spleen Cells
Bone marrow cells were extracted from both the femurs and tibias
of uninfected and P. berghei-infected mice by flushing out the
marrow with 1 ml RPMI 1640 media (Life Technologies) using a
26-gauge needle. Spleen cells were isolated by mashing the entire
spleen in 5 ml RPMI 1,640 media and passing the cells through
a 40 µm nylon mesh cell strainer (Interpath). The cells were
centrifuged at 1,000 × g and the pellet was resuspended in PBS
buffer containing 1% (w/v) bovine serum albumin (BSA).
Antibody Staining for Flow Cytometric
Analysis
Bone marrow or spleen cells at 106 cells/50 µl were incubated
with anti-mouse CD16/CD32 (Fcγ III/II Receptor; 2.5 µg/106
cells) for 15 min on ice. Samples were subsequently stained
with PE-conjugated anti-mouse Ter-119 (0.5 µg/106 cells),
APC-conjugated anti-mouse CD44 (IM7; 0.2 µg/106 cells),
APC-Cy7-conjugated anti-CD11b (M1/70; 0.1 µg/106 cells),
FITC-conjugated anti-GR-1 (RB6-8C5; 0.1 µg/106 cells), PE-
conjugated anti-Ly6G (1A8; 0.1 µg/106 cells), BV421-conjugated
anti-CD11c (N418; 0.2 µg/106 cells) on ice for 20–30 min in the
dark. Cells were pelleted at 1,000 × g, washed in PBS containing
1% (w/v) BSA and resuspended in 0.2 ml of PBS containing
1% (w/v) BSA. The cells were then incubated with 7-AAD
(2 µl/1 × 106) cells for 10 min to allow live/dead discrimination
prior to FACS analysis.
For analysis of STAT5 activation, bone marrow or spleen
cells were first pelleted at 1,000 × g at 4◦C and resuspended
in 1 ml of phosphowash buffer [1 × PBS, 1 mM sodium
orthovanadate, 1 mM β-glycerol phosphate and 100 mM sodium
fluoride containing 1 × PhosSTOP inhibitors (Sigma)]. To this
buffer, PE-conjugated anti-Ter119 and APC-conjugated anti-
CD44 in conjunction with VS-450 were added as above and
samples incubated for 30 min on ice. The cells were then
treated with 30 international units (I.U) of erythropoietin (EPO)
(Janssen, United Kingdom) at 37◦C for 30 min. Following this,
the cells were pelleted and resuspended in fixing buffer (2%
(v/v) paraformaldehyde and 0.0075% (v/v) glutaraldehyde in PBS
containing 3% (w/v) BSA) for 10 min at room temperature (RT),
before quenching with phosphowash buffer containing 500 mM
Tris for 10 min at RT, washing with phosphowash buffer, and
then permeabilization with phosphowash buffer containing 0.2%
(v/v) Triton-X for 10 min at RT. The cells were washed with
phosphowash buffer and resuspended in 100 µl phosphowash
buffer containing either AF488-conjugated anti-phospho-STAT5
antibody (pY694) or the isotype control AF488-conjugated anti-
mouse IgG1, κ (20 µl/106 cells). After incubation for 30 min
on ice, cells were washed twice and resuspended in 200 µl
phosphowash buffer for FACS analysis.
Flow Cytometry and Cell Sorting
A minimum of 10,000 and up to 10,000,000 stained cells
were analyzed by flow cytometry with a BD FACS CANTO II
flow cytometer (BD Biosciences) equipped with blue (488 nm,
20 mW), red (633 nm, 17 mW), and violet (405 nm, 30 mW)
lasers. In circumstances where cells were sorted, a BD FACS
Aria II cell sorter, equipped with violet (405 nm, 50 mW),
blue (488 nm, 20 mW), and red (633 nm, 18 mW) lasers,
was used. Events were collected using FACS Diva software
or BD FACS software. Cell debris and noise were removed
from gating analysis based on FSC/SSC properties. Single cells
were gated based on the FSC area to height ratio. Live/dead
cell discrimination was achieved using 7-AAD or VS-450 and
only live cells were analyzed further. Compensation and further
analysis was performed using FlowJo v.10.0.6 (Tree Star).
Methyl Cellulose Colony Assay for
Mouse Hematopoietic Progenitor Cells
Bone marrow cells were harvested aseptically from femurs
and tibias of mice using Iscove’s modified Dulbecco’s medium
(IMDM) (Sigma) containing 2% (v/v) FBS and resuspended
to a final concentration of 5 × 105 cells/100 µl IMDM. To
this cell suspension, 1 ml of methyl cellulose (R&D systems)
was added and mixed by vortexing before being spread onto a
5 ml cell culture dish and incubated at 37◦C with 5% CO2. On
days 4 and 8 after plating, colonies were enumerated using an
inverted microscope (40×magnification) and identified as either
CFU-GEMM (colony forming unit-granulocyte, erythrocyte,
monocyte, and megakaryocyte), CFU-GM (colony forming unit-
granulocyte and macrophage), CFU-G (colony forming unit-
granulocyte) CFU-M (colony forming unit-macrophage), CFU-E
(colony forming unit, erythroid), or BFU-E (burst forming unit,
erythroid) based on their morphology. The numbers of CFU-Meg
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(CFU-megakaryocytes) could not be determined as their growth
is not supported by the methyl cellulose used in the assay.
Microscopy
Peripheral blood smears stained with Giemsa were visualized by
light microscopy at 100× (NA 1.25) magnification under oil.
Cells from the methyl cellulose colony assay were visualized by
light microscopy at 40× (NA 0.95) magnification. Erythroblasts
parasitized with GFP-expressing parasites were labeled with
PE-conjugated anti-mouse Ter119 and the nuclear stain 4′,6-
diamidino-2-phenylindole (DAPI, 500 ng/nl) (Vector Labs) and
visualzed on an Olympus IX71 inverted wide field microscope
equipped with DAPI (Excitation 330–385/emission 420), GFP
(470–595/510–550) and DsRed (545–580/610IF) filter cubes at
100× (NA 1.37) magnification under oil. Images were processed
using ImageJ version 1.47d1.
Serum Cytokine Analysis
Mouse serum was obtained by centrifuging mouse blood that
had been allowed to clot at RT for 30 min at 5,000 × g for
10 min at 4◦C and harvesting the supernatant. Cytokine levels
in the serum were measured using the ProcartaPlex Mouse
Cytokine and Chemokine Panel 1 kit (26 plex, eBioscience)
according to manufacturer’s instructions. The cytokines and
chemokines analyzed were IL-12, IL-23, IL-27, CCL2 (MCP-1),
CCL5 (RANTES), CCL7 (MCP-3), CXCL1 (GRO-α), CXCL10
(IP-10), Eotaxin, GM-CSF, IFN-γ, IL-1β, IL-10, IL-13, IL-17A,
IL-18, IL-2, IL-22, IL-4, IL-5, IL-6, IL-9, MIP-1α, MIP-1β, TNF-
α, and MIP-2. Serum EPO levels were separately quantified
using a mouse EPO ELISA kit (Sigma-Aldrich) according to
manufacturer’s instructions.
Statistical Analysis
Statistical analysis was performed using Graph Pad prism v6
(GraphPad Software, La Jolla, CA, United States). For all
experiments, an unpaired Student’s t-test was used to compare
two groups. A p-value < 0.05 was considered significant.
RESULTS
Changes to the Cellularity of the Bone
Marrow and Spleen During a P. berghei
Infection
To investigate the erythropoietic response to acute P. berghei
infection, groups of female Balb/c mice (n = 6) were infected with
106 P. berghei-parasitized RBCs (pRBCs). As expected, significant
parasitemia was observed, with a mean parasitemia of 6.1% at
5 dpi, increasing to 15.8% at 8 dpi (Figure 1A). Mice were anemic
by 5 dpi, based on significant decreases in their hemoglobin
levels and hematocrit (Figure 1A). Nevertheless, the RBCs
remained normocytic as determined by measuring the mean
corpuscular volume (0 dpi, 17.40 ± 0.15; 7 dpi, 17.43 ± 1.09)
and mean corpuscular hemoglobin (0 dpi, 46.33 ± 0.53; 7 dpi,
1http://rsbweb.nih.gov/ij
49.05 ± 0.97). P. berghei-infected mice showed a dramatic
decrease in bone marrow cellularity, whilst the total number of
cells in the spleen markedly increased over the course of infection
(Figure 1A), consistent with the splenomegaly observed in these
mice (data not shown).
Changes to the Erythroid Populations in
the Bone Marrow and Spleen
To specifically examine the erythroid lineage in the bone marrow
and spleen, Ter119 was used as a marker for erythroid cells at
all stages of differentiation, from early proerythroblasts to the
mature erythrocyte stage (Kina et al., 2000). The FACS gating
strategy used for the analysis is outlined in Figure 1B. Both the
total number and relative proportion of Ter119+ cells in the bone
marrow significantly decreased during infection (Figure 1A).
Conversely, there were no significant differences in the total
number of Ter119+ cells in the spleen at either 5 dpi or 8 dpi,
however, the proportion of Ter119+ cells relative to other cells in
the spleen did significantly increase at 5 dpi (Figure 1A).
Individual stages of erythroid maturation (proerythroblasts,
basophilic erythroblasts, polychromatic erythroblasts,
orthochromatic erythroblasts, reticulocytes, and RBCs) were
next analyzed based on size and expression of CD44 and Ter119
as described (Chen et al., 2009) (see Figure 1B for gating strategy
and Supplementary Figure S1 for representative FACS plots
at 0, 5, and 8 dpi). All erythroid stages except RBCs were
significantly decreased in the bone marrow by 5 dpi, with all of
these except basophilic erythroblasts decreasing further by 8 dpi,
by which time the mature RBCs were also significantly reduced
(Figure 2A). Analysis of the relative proportions of the various
erythroid stages in the bone marrow revealed that by 5 dpi,
basophilic and polychromatic erythroblast populations were
significantly reduced, while the proportions of proerythroblasts,
orthochromatic, and mature RBCs were significantly increased
(Figure 2B). At 8 dpi, the proportion of mature RBCs was
significantly decreased relative to proerythroblasts, basophilic
and polychromatic erythroblasts and reticulocytes (Figure 2B).
During normal steady-state erythropoiesis, a ratio of
1 proerythroblast (pro): 2 basophilic erythroblasts (baso):
4 polychromatic erythroblasts (poly): 8 orthochromatic
erythroblasts (ortho) is typically observed (Chen et al., 2009),
as seen in uninfected mice (Figure 2C). At 5 dpi, the baso: pro
ratio was significantly decreased in the bone marrow, while
the ortho:poly ratio was significantly increased (Figure 2C).
By 8 dpi the low baso:pro ratio had returned to normal levels,
however, the poly:baso and ortho:poly ratios were significantly
decreased (Figure 2C).
In the spleen, total numbers of all erythroid stages were
significantly increased by 5 dpi except for basophilic and
polychromatic erythroblasts (Figure 3A). By 8 dpi, significant
increases in total cell numbers were observed for all erythroid
stages, with the exception of mature RBC, which showed
no significant changes between 5 and 8 dpi (Figure 3A).
Interestingly, although the proportions of all blast populations
and reticulocytes in the spleen were significantly reduced on
5 dpi, by 8 dpi significant increases were observed for all
Frontiers in Microbiology | www.frontiersin.org 4 April 2020 | Volume 11 | Article 702
fmicb-11-00702 April 15, 2020 Time: 16:17 # 5
Lakkavaram et al. P. berghei Infection Perturbs Hematopoiesis
FIGURE 1 | Global impact of Plasmodium berghei infection. The global impact of malaria infection on blood parameters was measured (A), including blood
parasitemia as measured by examination of blood smears, hemoglobin levels and hematocrit using a hematology analyzer (top panel), as well as total cells, total
Ter119+ cells and percentage Ter119+ cells in the bone marrow and spleen (middle and bottom panels, respectively), by FACS analysis. Plotted are results from
individual mice as well as mean ± SD. An unpaired t-test was used to calculate statistical significance between two groups: *p < 0.05, **p < 0.01, ***p < 0.001,
****p < 0.0001. The FACS gating strategy for identifying Ter119+ cells and distinct stages of erythroid differentiation in the bone marrow and spleen described is
outlined (B). Cells were gated on size and granularity based on forward and side scatter to avoid debris. After selection of singlets, 7-AAD-negative live cells and
Ter119 (PE-positive) erythroid cells, distinct stages of erythroid differentiation were identified and quantified, using CD44 expression and cell size. Shown is example
of cells isolated from the bone marrow of uninfected Balb/c mice. Pro, proerythroblasts; Baso, basophilic erythroblasts; Poly, polychromatic erythroblasts; Ortho,
orthochromatic erythroblasts; Retics, reticulocytes; RBC, red blood cells. Other populations outside the areas gated remain undefined (Chen et al., 2009).
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FIGURE 2 | Impact of P. berghei infection on erythroblast maturation dynamics in the bone marrow. Analysis of the total number (A) and proportion of Ter119+ cells
(B) of the indicated stages of erythrocyte maturation in the bone marrow during a P. berghei infection using the gating strategy outlined in Figure 1B. Plotted are the
results from individual mice as well as mean ± SD (n = 6 mice). From the data in (B), the ratio of the indicated erythrocyte populations was determined, with
mean ± SD shown (C). An unpaired t-test was used to calculate statistical significance between two groups: *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.
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populations except for mature RBCs, which were significantly
decreased, even below naïve levels (Figure 3B). Erythroblast
ratios were not significantly altered until 8 dpi, at which time the
baso:pro ratio was significantly increased whereas the poly:baso
and ortho:poly ratios were significantly decreased (Figure 3C).
Plasmodium berghei Does Not Infect
Erythroblasts
Plasmodium berghei parasites are known to preferentially invade
reticulocytes in the blood (Cromer et al., 2006), thereby directly
interfering with their differentiation. To investigate whether
P. berghei can also infect erythroblasts and modulate their
maturation, Balb/c mice were infected with P. berghei EXP2-
2A-FRT parasites expressing a GFP reporter (Pb-GFP) that
is exported into the host cell (Kalanon et al., 2016), thereby
enabling identification of parasite-infected cells. Spleens were
harvested from mice infected with Pb-GFP parasites at 8 dpi
and cells were analyzed for Ter119 and GFP co-expression by
flow cytometry. Erythroblasts were also sorted based on CD44
and Ter119 expression and then stained with DAPI prior to
microscopy. Whilst GFP expression could be readily detected
in reticulocytes, this was not the case with erythroblasts, with
very few erythroblasts expressing even a weak GFP signal
(Supplementary Figures S2A,B). Thus, the ability of P. berghei
to infect erythroblasts is unlikely to be a significant factor in the
perturbation of erythroblast maturation.
Infected Mice Show Increased Serum
EPO Levels
Erythropoietin is a key mediator of emergency erythropoiesis
in response to low oxygen tension (Koury et al., 1989),
therefore another mechanism by which the perturbation in
erythropoiesis could be mediated is through defective EPO
production. Serum EPO levels significantly increased during
P. berghei infection (Figure 4), which correlated with the reduced
hematocrit to an extent. This indicates that the inefficient
erythropoiesis in infected mice was not due to an overt deficiency
in EPO production.
EPO-Mediated STAT5 Activation in
Erythroblasts Is Not Altered During
Infection
Erythropoiesis could also be impacted by altered signaling by
the EPO receptor. Expression of the EPO receptor peaks at the
CFU-E and proerythroblast stage and decreases with further
blast maturation such that by the reticulocyte stage expression
is undetectable (Broudy et al., 1991). Signal transducer and
activator of transcription 5 (STAT5) is a key downstream target of
EPO receptor signaling, being responsible for the transcriptional
activation of many key genes involved in erythropoiesis
(Gillinder et al., 2017). Therefore, levels of phosphorylated STAT5
(pSTAT5) were used as a measure of receptor activation in the
Ter119+ erythroblast population from the bone marrow and
spleen, either directly or after EPO stimulation ex vivo. The
gating strategy to obtain erythroblasts is outlined in Figure 5A.
An isotype control antibody was used in place of the anti-
phospho STAT5 antibody to control for non-specific FITC
labeling of erythroblasts.
Levels of pSTAT5 in unstimulated bone marrow and splenic
erythroblasts harvested from uninfected and P. berghei-infected
mice were low, as indicated by only subtle increases in anti-
pSTAT5 labeling compared to the isotype control antibody
(Figures 5B,C, upper panels). After stimulation with EPO,
pSTAT5 activity increased in all cell populations relative to cells
that had not been stimulated with EPO (Figures 5B,C, upper
panels). However, no significant differences were observed in
the fold-change of pSTAT5 levels in bone marrow or splenic
erythroblasts from infected mice relative to uninfected mice,
either before or after EPO stimulation (Figures 5B,C, lower
panels). This indicates that perturbed EPO receptor signaling
is not responsible for the lack of erythroblast differentiation
observed in P. berghei-infected mice.
Effect of P. berghei Infection on Other
Hematopoietic Populations in the Bone
Marrow and Spleen
The BFU-E erythroid lineage is derived from the same common
hematopoietic progenitor cell (CFU-GEMM) that yields CFU-
Meg (megakaryocyte precursors) and CFU-GM (precursors to
CFU-G and CFU-M from which neutrophils and monocytes,
respectively, are derived). Therefore, these populations in the
bone marrow and spleen were also examined during P. berghei
infection to provide a global view of hematopoiesis, with the
gating strategy outlined in Figure 6A. Representative FACS plots
at 0, 5, and 8 dpi are shown in Supplementary Figure S3.
Similar to the Ter119+ population, the total number of
CD61+ megakaryocytic cells significantly decreased in the
bone marrow at 5 dpi, with even fewer cells present at
8 dpi (Figure 6B). In contrast, megakaryocytic cell numbers
significantly increased in the spleen over the timecourse
(Figure 6C). The proportion of CD61+ cells in both the
bone marrow and spleen were significantly decreased at 8 dpi
(Figures 6B,C), indicating thrombocytopenia with late infection.
In keeping with the changes to overall cellularity of the bone
marrow in response to infection, total numbers of monocytes and
neutrophils in the bone marrow significantly decreased by 5 dpi
(Figure 6B). The proportions of monocytes and neutrophils in
the bone marrow were also significantly lower at 5 dpi compared
to uninfected mice. However, at 8 dpi the proportions of these cell
types had rebounded to levels significantly higher than at 0 dpi
(Figure 6B). In contrast, the total numbers of monocytes and
neutrophils increased significantly in the spleen during infection
(Figure 6C). However, the proportion of monocytes in the spleen
was significantly reduced at 5 dpi to a level that was maintained
at 8 dpi, whilst the proportion of neutrophils was significantly
reduced at 5 dpi, and notably more so at 8 dpi (Figure 6C).
Differentiation of Hematopoietic Cells in
the Bone Marrow During Infection
To gain further insight into observed alterations in the erythroid,
megakaryocyte and myeloid lineages during the course of
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FIGURE 3 | Impact of P. berghei infection on erythroblast maturation dynamics in the spleen. Analysis of the total number (A) and proportion of Ter119+ cells (B) of
the indicated stages of erythrocyte maturation in the spleen during a P. berghei infection using the gating strategy outlined in Figure 1B. Plotted are the results from
individual mice as well as mean ± SD (n = 6 mice). From the data in (B), the ratio of erythroblast populations was determined with mean ± SD shown (C). An
unpaired t-test was used to calculate statistical significance between two groups: *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.
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FIGURE 4 | Analysis of erythropoietin levels during P. berghei infection. Levels
of EPO (pg/ml) in the serum of mice during a P. berghei infection was
quantified using an EPO ELISA kit. Plotted are the results from individual mice
as well as mean ± SD (n = 6–8 mice). An unpaired t-test was used to
calculate statistical significance between two groups: *p < 0.05, **p < 0.01.
infection, early progenitors in bone marrow and spleen were
analyzed using a colony forming unit (CFU) assay. At 5 dpi,
the total numbers of all CFUs in the bone marrow were not
significantly different to 0 dpi, with the exception of BFU-
E, which was significantly decreased twofold (Figure 7A). By
8 dpi, the total number of CFUs in the bone marrow was
significantly decreased for all colony types, with CFU-E showing
the greatest decline (∼30-fold) (Figure 7A). However, when
the relative frequencies of the different CFUs per 105 cells was
determined, the proportion of CFU-GM, CFU-G, and CFU-M
was significantly increased at 5 dpi and remained significantly
higher for CFU-GM and CFU-G at 8 dpi (Figure 7B). In contrast,
the proportion of BFU-E was significantly decreased at 5 dpi but
had returned to pre-infection levels by 8 dpi, whilst CFU-E was
significantly decreased by this stage. CFU-GEMM did not change
during infection (Figure 7B).
In the spleen, there was a marked and statistically significant
increase in the total numbers of all CFUs by 5 dpi and, with
the exception of CFU-GEMM, all populations further increased
by 8 dpi (Figure 8A). Similarly, the frequency of all CFUs in
the spleen was increased at 5 dpi, except for CFU-GEMM and
CFU-GM, with the latter significantly decreasing. However, only
CFU-G had increased further by 8 dpi, with CFU-GM decreasing
further and both BFU-E and CFU-E frequency decreasing
although remaining higher than at 0 dpi (Figure 8B).
Infected Mice Show Increased Serum
Levels of Proinflammatory Cytokines and
Chemokines
Cytokines are known to play a key role in determining
the outcome of a Plasmodium infection (i.e., pathogenesis
or protection) (Angulo and Fresno, 2002). Therefore, the
concentration of a range of cytokines in the sera was also
examined. Of the pro-inflammatory cytokines, IFN-γ, TNF-α,
IL-6, IL-18, and IL-23 were significantly increased in response
to P. berghei infection (Figure 9A). Although IL-17 levels were
below the lower limit of quantification, they also increased upon
infection (Figure 9A). The only anti-inflammatory cytokine that
increased was IL-10 (Figure 9B). Several chemokines, including
IP-10 (CXCL10), CCL2 (MCP-1), CCL3 (MIP-1α), CCL4 (MIP-
1β), CCL5 (RANTES), and CCL7 (MCP-3) were also significantly
increased upon infection (Figure 9C). Other pro-inflammatory
and anti-inflammatory cytokines and chemokines that were
measured and which did not significantly change in response to
infection are shown in Supplementary Figure S4.
DISCUSSION
In this study we sought to characterize the mechanisms
underpinning anemia in a rodent model of acute malaria,
including whether optimal pro-inflammatory responses can
be mounted to fight infection and whether this impacts on
the erythrocyte compartment. Infection of Balb/c mice with
P. berghei led to the development of anemia by 5 dpi, with
both blood hemoglobin levels and hematocrit ∼60% that of
uninfected mice, and declining even further to ∼50% by 8 dpi,
underlining the substantial hemolysis of circulating RBC elicited
by this pathogen (Evans et al., 2006; Lamikanra et al., 2007).
The infection also led to a striking decrease in bone marrow
cellularity (∼75% reduction), which was consistent with other
rodent infection studies (Rencricca and Coleman, 1979; Maggio-
Price et al., 1985; Asami et al., 1992). At 5 dpi, there was
a significant decline in the proportion of BFU-E in the bone
marrow, although the proportion of CFU-Es was still maintained,
indicating that the BFU-Es were capable of differentiating into
CFU-E at this time. By 8 dpi, however, the proportion of BFU-
E in the bone marrow had increased, but the proportion of
CFU-E had significantly declined and although the proportion of
erythroblasts increased at this time as RBCs (and reticulocytes)
entered the circulation, this was insufficient to compensate for
the anemia as the hematocrit did not recover. The impact of
Plasmodium infection may, therefore, be analogous to cases of
chronic erythroid stress including hemolysis, where low numbers
of CFU-E progenitors results in insufficient production of RBCs
and consequential triggering of BFU-E production (Dolznig et al.,
2006). In addition, there were clear perturbations to steady-
state erythropoiesis in the bone marrow of infected mice, with
the differentiation of the early erythroblasts into more mature
erythroblasts impaired. The most profound defect was at the
polychromatic and orthochromatic erythroblast stages, which
are the stages when hemoglobin production peaks (Granick and
Levere, 1964). A similar defect in erythroblast maturation was
also observed in a Plasmodium chabaudi rodent infection study
(Chang and Stevenson, 2004).
The reduction in bone marrow cells was not restricted to
the erythroid lineage since the total number of cells within
the megakaryocyte, monocyte and neutrophil lineages were
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FIGURE 5 | Analysis of STAT5 activation during P. berghei infection. Gating strategy to detect pSTAT5 responses in erythroblasts (A). Fixed and permeabilized
spleen cells following removal of debris (i) were stained with APC-conjugated CD44, PE-conjugated Ter119 and AF488-conjugated pSTAT5 antibodies and 7-AAD.
After selection of singlets, live cells and Ter119+ cells, erythroblasts were gated based on CD44 expression and cell size and pSTAT5 staining quantified. STAT5
activation in Ter119+ erythroblasts from the bone marrow (B) and spleen (C) before and after ex vivo EPO stimulation as measured by FACS with anti-pSTAT5.
Shown in the upper panels are representative medium intensity histograms of samples analyzed with anti-pSTAT5 compared to an isotype control in the presence or
absence of EPO stimulation, as indicated. Data in the lower panels represents the ratio of MFI from cells stimulated with EPO to unstimulated cells as well as the
fold-change ± EPO from individual mice as well as the mean ± SD (n = 6 mice). An unpaired t-test was used to calculate statistical significance between two
groups. *p < 0.05.
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FIGURE 6 | Impact of P. berghei infection on megakaryocyte, neutrophil, and monocyte populations in the bone marrow and spleen. Gating strategy for identifying
megakaryocytic, monocyte, and neutrophil cells (A). For megakaryocytic cells (top panel), cells were firstly gated on size and granularity based on forward and side
scatter to remove debris. FSC-H and FSC-A plots were then used to identify singlets. Only live cells, which are negative for 7-AAD staining were analyzed for CD61
and GR1 staining. Cells positive for CD61 but negative for Gr1 (i.e., those in Q1) were gated and analyzed. Shown is example of cells isolated from the bone marrow
of uninfected Balb/c mice. Gating strategy for monocytes and neutrophils (bottom panel). Cells were gated on size and granularity based on forward and side scatter
to remove debris. After selection of singlets and live cells, cells were analyzed for CD11c and CDl1b staining. Cells positive for CD11b but negative for CD11c were
gated on to remove dendritic cells and the resulting cell population was analyzed for Gr1 and Ly6G expression to distinguish between neutrophils (Gr-1+, Ly6G+)
and monocytes (Gr-1+, Ly6G-). Shown is example of cells isolated from the bone marrow of uninfected Balb/c mice. CD61+ megakaryocytes, CD11b+Gr1+Ly6G-
monocytes and CD11b+Gr1+Ly6G+ neutrophils in the bone marrow (B) and spleen (C) during the course of a P. berghei infection were then examined, from which
the total number (top panel) and proportion of cells (lower panel) were calculated. Plotted are the results from individual mice as well as mean ± SD (n = 6 mice). An
unpaired t-test was used to calculate statistical significance between two groups: *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.
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FIGURE 7 | Impact of P. berghei infection on colony forming units in the bone marrow. Analysis of the total number (A) and the proportion (B) of CFUs present in the
bone marrow, which were determined by assessing the morphology of colonies of bone marrow cells by microscopy after incubation in medium containing methyl
cellulose and relevant cytokines. Data represents the mean ± SD (n = 4 independent experiments). An unpaired t-test was used to calculate statistical significance
between two groups: *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.
also decreased upon infection. This was also reflected in
decreased numbers of myeloid progenitor cells. The overall
hematopoietic changes in the bone marrow may stem from
several mechanisms. These include reduced proliferative capacity
(for example, in response to inflammatory signals) (King and
Goodell, 2011) and/or decreased survival of progenitors, both
of which are known to be triggered by the production of
hemozoin from hemoglobin by parasite infection (Lamikanra
et al., 2009). However, mobilization of mature RBCs into the
blood in response to the decline in hematocrit, monocytes, and
neutrophils (and other innate immune cells) to relevant tissues in
direct response to the infection, and progenitors to other sites,
particularly the spleen, would also likely be significant factors
(Hoggatt and Pelus, 2011).
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FIGURE 8 | Impact of P. berghei infection on colony forming units in the spleen. Analysis of the total number (A) and the proportion (B) of CFUs present in the
spleen, which were determined by assessing the morphology of colonies of spleen cells by microscopy after incubation in medium containing methyl cellulose and
relevant cytokines. Data represents the mean ± SD (n = 4 independent experiments). An unpaired t-test was used to calculate statistical significance between two
groups: *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.
Indeed, spleen cellularity increased as the infection
progressed, consistent with the observed splenomegaly that
is a hallmark of Plasmodium infection (CDC, 2019). Increased
numbers of BFU-E, CFU-E and erythroblasts were observed at
5 dpi. The additional BFU-Es may have migrated from the bone
marrow to the spleen in response to emergency erythropoiesis
(Goris et al., 1990), but spleen-resident stress erythroid
progenitor cells (called stress BFU-E) (Lenox et al., 2005)
likely also account for the increase in CFUs and erythroblasts
observed in the spleen. However, despite initial increases in
BFU-E and CFU-E numbers in the spleen, by 8 dpi they were
significantly decreased. This coincided with an increase in
the proportions of erythroblast and reticulocyte proportions,
indicating enhanced differentiation into more mature erythroid
cells, presumably to compensate for declining RBC numbers
in circulation. However, steady-state erythropoiesis was also
perturbed in this organ in a similar manner to that observed
in the bone marrow, with the differentiation of the early
erythroblasts into more mature erythroblasts significantly
affected at 8 dpi.
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FIGURE 9 | Analysis of pro-inflammatory and anti-inflammatory cytokines and chemokines during P. berghei infection. Levels of proinflammatory cytokines (A),
anti-inflammatory cytokines (B), and chemokines (C) were measured with a ProcartaPlex Mouse Cytokine and Chemokine Panel 1 kit and those that were
significantly upregulated in the serum of infected mice at 7 dpi are shown. The lower limits of detection are indicated by a dotted line. Data represents results from
individual mice as well as the mean ± SD (n = 6 mice). An unpaired t-test was used to calculate statistical significance: *p < 0.05, **p < 0.01, ***p < 0.001.
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The numbers of splenic myeloid progenitor cells were
also increased in P. berghei-infected mice. Myeloid restricted
progenitor cells have been shown to migrate to the spleen
in response to a Plasmodium chaubaudi infection, a response
that was dependent on IFN-γ signaling (Sponaas et al.,
2009; Belyaev et al., 2013). We also observed an increase in
monocyte/macrophages and neutrophil numbers, which is in
keeping with the important role played by macrophages in
removing pRBC and uninfected RBC that circulate through
the spleen (Evans et al., 2006). The significant decrease in
the proportion of mature RBCs in the spleen is likely to be
attributable to their mobilization into the blood.
Taken together, our findings are consistent with the findings
summated from a diverse variety of human and rodent studies
utilizing different Plasmodium species. For example, those that
have shown reduced BFU-E and CFU-E numbers in the bone
marrow of infected mice (Maggio-Price et al., 1985), suppressed
erythropoiesis in the spleen and bone marrow during the
early stages of infection (using microarray analysis) (Sexton
et al., 2004), lower numbers of BFU-E in the bone marrow
of P. falciparum-infected children from Gambia who exhibited
moderate to severe malaria (Abdalla and Wickramasinghe,
1988) and suppressed in vitro development of CD34+/erythroid
progenitor cells following exposure to P. vivax (Panichakul et al.,
2012). Collectively this suggests similar underlying mechanisms,
thereby validating the P. berghei mouse infection model.
Using a GFP-expressing parasite line, we demonstrated that
no significant infection of erythroblasts occurred, ruling this
possibility out as a major contributor to disrupted erythroblast
maturation. Similarly, low levels of the erythropoiesis-
stimulating cytokine EPO were not responsible; on the contrary,
serum EPO levels actually increased during the infection,
consistent with the higher EPO levels observed after infection
of mice with P. chabaudi (Chang and Stevenson, 2004) and in
several human studies examining patients with P. falciparum
anemia (Burchard et al., 1995; Verhoef et al., 2002). We extended
our studies to examine the EPO-responsiveness of erythroblasts
by analyzing the activation of STAT5, which lies downstream of
the EPO receptor (Damen et al., 1995), and show for the first time
that this was not significantly affected. Whether downstream
responses of pSTAT5 were impaired in erythroblasts cannot be
ruled out. However, other studies have shown that expression of
the essential erythroid-promoting transcription factor GATA1
was reduced in the bone marrow of P. berghei-infected C57/Bl6
mice (Sexton et al., 2004) and in human erythroid cells co-
cultivated with hemozoin-laden human monocytes, with the
erythroid cells also exhibiting reduced expression of the receptors
for EPO and transferrin (Skorokhod et al., 2010). Indeed it has
been suggested that defects in erythroblast maturation during
infection may stem from transferrin receptor expression shifting
from Ter119+ cells to non-erythroid cells (Chang and Stevenson,
2004), which would in turn affect the ability of erythroblasts
to take up iron and thus synthesize the hemoglobin required
for erythroblast maturation, however, this was not measured
in our study. Iron availability for erythropoiesis is likely to be
separately limited as hepcidin is known to be upregulated in
malaria infection (Howard et al., 2007; Wang et al., 2011).
A common myeloid progenitor cell yields erythroid cells
and megakaryocytes via a megakaryocyte-erythroid progenitor
(MEP) as well as neutrophils and monocytes/macrophages via
a granulocyte-macrophage progenitor (GMP). The observed
perturbation to the erythroid lineage in the bone marrow of
the P. berghei-infected mice most likely occurred at the level
of the MEP since the proportion of both Ter119+ erythroid
cells and CD61+ megakaryocyte cells declined, whilst that of
the CD11b+Gr1+Ly6G− monocytes and CD11b+Gr1+Ly6G+
neutrophils were significantly increased at 8 dpi. Cells of the
myeloid and lymphoid lineage release inflammatory cytokines
and chemokines that have been shown to contribute or associate
with anemia (Kern et al., 1989; Lyke et al., 2004; Ong’echa et al.,
2008). Infected mice showed an increase in TNF-α which has
previously been shown to inhibit all stages of erythropoiesis
(Dufour et al., 2003), and IFN-γ, which has been shown to
upregulate the expression of multiple members of the TNF
superfamily responsible for inhibiting erythroid growth and
differentiation (Miller et al., 1989; Felli et al., 2005). In addition,
IFN-γ activation of macrophages can also lead to increased
hemophagocytic activity in the spleen, resulting in the loss of
erythrocytes via endocytosis (Zoller et al., 2011). Increases were
also observed in the levels of IL-6, IL-10, IL-18, IL-23, and
RANTES. Interestingly, IL-6 induces hepcidin, which negatively
affects erythropoiesis by inducing iron deficiency (Nemeth et al.,
2004), whereas cytokines such as IL-18 and IL-23 (which are
produced by monocytes and/or macrophages in addition to
other cells) increase IFN-γ production (Nakamura et al., 1989).
Although the IL-17 levels in the mice were too low to determine
whether the increase upon infection was indeed significant, this
cytokine, which is produced by Th17 cells in response to IL-23,
induces chemokines and IL-6 and acts in concert with TNF-α
to induce inflammation (McGeachy et al., 2019) and has been
shown to be crucial for maintenance of splenic macrophages in
P. berghei-infected mice (Ishida et al., 2013). Thus, taken together
the pathophysiology of malaria-associated anemia overlaps to
some degree with anemia of chronic disease, a cytokine-mediated
anemia (Means, 1995; Weiss and Goodnough, 2005). Increases
were also seen in the levels of the chemokines CCL2 (MCP-
1), CCL3 (MIP-1α), CCL4 (MIP-1β), and CCL7 (MCP-3),
which are all potent monocyte chemoattractants and activators,
suggesting that monocyte/macrophages are central to these
processes. Malaria is not the only infectious disease that leads
to bone marrow disruption and depletion of progenitor cells;
inflammatory mediators liberated in response to other pathogens
can also have indirect effects on bone marrow progenitor cells,
in addition to effects caused by direct infection of progenitor
cells or recognition of the pathogen by these cells. Examples
include chronic infections with human immunodeficiency virus
and Mycobacterium avium and infections with the tick-borne
pathogen Ehrlichia muris and the parasite Toxoplasma gondii
(Glatman Zaretsky et al., 2014).
Notably, the cytokine and chemokine responses observed
in our study are consistent with other studies. For example,
injection of hemozoin into Balb/c mice led to the upregulation
of transcripts encoding IL-6 and chemokines CCL2, CCL3, and
CCL4 (Jaramillo et al., 2004). In addition, levels of IL-23 were
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higher in the peripheral blood of Kenyan children with malaria
anemia (Ong’echa et al., 2008), whilst IL-18 promoter haplotypes
that result in elevated IL-18 expression during acute infection
have been associated with increased risk of SMA (Anyona et al.,
2011). Gabonese children with severe malaria were found to
have elevated levels of CCL3 and CCL4 in their circulation
(Ochiel et al., 2005). Malian children with SMA showed elevated
plasma IL-10 levels relative to healthy controls (Lyke et al., 2004).
However, a low IL-10 to TNF-α ratio is associated with enhanced
severity to malaria anemia (Othoro et al., 1999) and reduced
serum IL-10 was observed in pediatric patients from Ghana with
SMA (Kurtzhals et al., 1998). Other studies have also indicated a
low concentration of serum RANTES is associated with anemia
(Were et al., 2006, 2009). Finally, IL-12 and MIF have also been
implicated in the pathophysiology of anemia (Martiney et al.,
2000; Chaiyaroj et al., 2004) but we did not observe a significant
increase in IL-12, nor did we measure levels of MIF.
In summary, the results from this study point to the acute
anemia resulting from a P. berghei infection being due, at least
in part, to direct hemolysis and RBC destruction but also the
release of pro-inflammatory cytokines and chemokines that serve
to inhibit erythroid development. It should be noted that the
identity of the cells responsible for liberating the inflammatory
cytokines and chemokines during infection were not analyzed as
part of this study. Based on the changes to the myeloid numbers
and increase in cytokines and chemokines that are known to
be macrophage chemoattractants and activators, monocytes are
likely to play a central role, serving as a defense mechanism
to control the infection and giving rise to a pathophysiology
with similarities to anemia of chronic disease. By defining the
hematopoietic changes that occur during a Plasmodium infection
in our validated model, this will complement human studies and
help to gain a deeper understanding on the pathophysiology of
anemia. For example, the five single nucleotide polymorphisms
in the human Cytokine-inducible Src homology 2 domain-
containing protein (CISH) gene (three of which lie in the
promoter region) that have been associated with increased risk to
malaria (Khor et al., 2010) can now be experimentally validated
for the contribution to malaria anemia using Cish knockout mice
infected with P. berghei.
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FIGURE S1 | Representative FACS plots of erythroblasts isolated from the bone
marrow and spleen of mice at different stages of infection. Ter119+ cells in the
bone marrow (A) and spleen (B) at distinct stages of erythroid differentiation were
identified and quantified based on the gating strategy outlined in Figure 1.
Representative FACS blots of cells harvested from mice at 0, 5, and 8 dpi are
shown. Pro, proerythroblasts; Baso, basophilic erythroblasts; Poly, polychromatic
erythroblasts; Ortho, orthochromatic erythroblasts; Retics, reticulocytes; RBC,
red blood cells.
FIGURE S2 | Parasitism of erythroblasts by P. berghei. Erythroblasts
(CD44+Ter119+) from the spleen of mice infected with P. berghei EXP2-FRT-HA
parasites expressing a GFP reporter were analyzed for GFP expression by FACS
(A). Erythroblasts (CD44+Ter119+) were also sorted by FACS, stained with DAPI
(to stain the nucleus) and analyzed for GFP expression by fluorescence
microscopy (B). P. berghei-infected (Pb) RBC and uninfected erythroblasts served
as negative controls, whilst P. berghei-GFP infected reticulocytes served as
positive controls for GFP expression. Scale bar 5 µm.
FIGURE S3 | Representative FACS plots of CD61+ megakaryocytes, neutrophils,
and monocytes isolated from the bone marrow and spleen of mice at different
stages of infection. The numbers of megakaryocytes (CD61+, Gr1−), neutrophils
(Gr-1+, Ly6G+), and monocytes (Gr-1+, Ly6G−) in the bone marrow (A) and
spleen (B) were identified and quantified based on the gating strategies outlined in
Figure 6. Representative FACS blots of cells harvested from mice at 0, 5, and
8 dpi are shown.
FIGURE S4 | Pro-inflammatory and anti-inflammatory cytokines and chemokines
that were not significantly altered in the serum during P. berghei infection. Levels of
the indicated proinflammatory cytokines (A), anti-inflammatory cytokines (B), and
chemokines (C) that did not significantly change in the serum of infected mice at
7 dpi. The lower limits of detection are indicated by a dotted line. Data represents
results from individual mice as well as the mean ± SD (n = 6 mice). An unpaired
t-test was used to calculate statistical significance.
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